Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets

Eli Lilly Deferred Tax Assets and Other Non-Current Assets increased by 3.4% to $7.23B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.0%, from $6.07B to $7.23B. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets and Other Non-Current Assets shows an upward trend with a 15.0% CAGR.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ4 2024

How to read this metric

An increase generally reflects a growing long-term asset base or deferred tax position, while a decrease suggests asset liquidation or tax benefit utilization.

Detailed definition

This is the aggregate balance of non-current deferred tax assets and other miscellaneous non-current assets not classifi...

Peer comparison

Commonly found in the non-current asset section of balance sheets for large, diversified financial firms.

Metric ID: deferred_tax_assets_other_noncurrent

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$3.64B$3.71B$4.08B$4.29B$4.47B$4.54B$4.34B$4.49B$4.67B$4.91B$4.99B$4.71B$4.90B$5.12B$5.72B$6.07B$6.23B$6.43B$6.99B$7.23B
QoQ Change+2.0%+10.0%+5.0%+4.3%+1.4%-4.4%+3.5%+4.1%+5.1%+1.6%-5.6%+4.2%+4.4%+11.7%+6.2%+2.5%+3.3%+8.7%+3.4%
YoY Change+22.9%+22.2%+6.2%+4.7%+4.5%+8.3%+15.1%+4.9%+5.0%+4.3%+14.6%+29.0%+26.9%+25.6%+22.2%+19.0%
Range$3.64B$7.23B
CAGR+15.6%
Avg YoY Growth+14.7%
Median YoY Growth+14.8%
Current Streak8 quarters growth

Frequently Asked Questions

What is Eli Lilly's deferred tax assets and other non-current assets?
Eli Lilly (LLY) reported deferred tax assets and other non-current assets of $7.23B in Q1 2026.
How has Eli Lilly's deferred tax assets and other non-current assets changed year-over-year?
Eli Lilly's deferred tax assets and other non-current assets increased by 19.0% year-over-year, from $6.07B to $7.23B.
What is the long-term trend for Eli Lilly's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Eli Lilly's deferred tax assets and other non-current assets has grown at a 15.0% compound annual growth rate (CAGR), from $3.48B to $6.99B.
What does deferred tax assets and other non-current assets mean?
The total value of long-term tax assets and other miscellaneous long-term assets.